We've noticed that you're using an ad blocker

Our content is brought to you free of charge because of the support of our advertisers. To continue enjoying our content, please turn off your ad blocker.

It's off now Dismiss How do I disable my ad blocker?
❌

How to disable your ad blocker for our site:

Adblock / Adblock Plus
  • Click on the AdBlock / AdBlock Plus icon on the top right of your browser.
  • Click “Don’t run on pages on this domain.” OR “Enabled on this site.”
  • Close this help box and click "It's off now".
Firefox Tracking Prevention
  • If you are Private Browsing in Firefox, "Tracking Protection" may casue the adblock notice to show. It can be temporarily disabled by clicking the "shield" icon in the address bar.
  • Close this help box and click "It's off now".
Ghostery
  • Click the Ghostery icon on your browser.
  • In Ghostery versions < 6.0 click “Whitelist site.” in version 6.0 click “Trust site.”
  • Close this help box and click "It's off now".
uBlock / uBlock Origin
  • Click the uBlock / uBlock Origin icon on your browser.
  • Click the “power” button in the menu that appears to whitelist the current website
  • Close this help box and click "It's off now".
  • Topics
  • Slideshows
  • Podcasts
  • Videos
  • Quizzes
  • Blogs
  • Conferences
  • Classifieds
  • All Content

Modern Medicine Network
  • Login
  • Register
Skip to main content
Modern Medicine Network
  • Login
  • Register
Menu
User
Home
  • Topics
  • Slideshows
  • Podcasts
  • Videos
  • Quizzes
  • Blogs
  • Conferences
  • Classifieds
  • All Content

SUBSCRIBE: eNewsletter

Neuro-Ophthalmologic Disorders
©VladimirArndt/Shutterstock

Neurologists may be the first or only clinicians to recognize the 5 potentially dangerous neuro-ophthalmologic conditions described in this article. ©VladimirArndt/Shutterstock

Recent Content

©StockLite/Shutterstock

Significant Improvement Found in Clinical Trial for Dravet Syndrome

  • Andrew N. Wilner, MD
Apr 26, 2018

An expert describes the efficacy of fenfluramine in decreasing seizure frequency associated with this rare syndrome.

©Wavebreakmedia/Shutterstock

A Challenging Case: Carbon Monoxide Poisoning and Parkinsonian Symptoms

  • Andrew N. Wilner, MD
Apr 26, 2018

A unique case of chronic, low level carbon monoxide poisoning in a car mechanic that resulted in Parkinsonian symptoms.

©Michael Taylor/Shutterstock.com

REM Sleep Behavior Disorder Predicts Neurodegeneration Risk

  • Andrew Wilner, MD
Apr 24, 2018

The presence of REM Behavior Disorder predicted an increased risk of Parkinson disease, Lewy Body dementia, or multisystem atrophy in the largest study ever performed in people with the strange disorder. Details here. 

©Stokkete/Shutterstock

Midlife Cardiovascular Fitness and Dementia in Women

  • Bobby Lazzara, MD
Apr 23, 2018

It looks like research is starting to support exercise as a reliable strategy to prevent dementia.

©BayanovaSvetlana/Shutterstock

Parkinson vs Alzheimer Dementia: A Clinical Sign

  • Andrew Wilner, MD
Apr 23, 2018

The finger displacement sign is a simple bedside test that can help distinguish Parkinson dementia from Alzheimer dementia.

©Everett Collection/Shutterstock

In Vivo Biomarkers for Chronic Traumatic Encephalopathy

  • Michael L. Alosco, PhD
  • Robert A. Stern, PhD
Apr 20, 2018

Chronic traumatic encephalopathy is a neurodegenerative disease that is believed to be a consequence of exposure to repetitive head impacts, including concussions and subconcussive injuries.

©Lightspring /Shutterstock.com

CGRPs: New Help in Migraine Prophylaxis?

  • Susan Kweskin
Apr 20, 2018

A new class of injectable monoclonal antibodies directed against calcitonin gene related peptide (CGRP) or its receptor may offer hope to migraineurs who have not found effective prophylactic therapy.

Mini Quiz: Beers Criteria

  • Veronica Hackethal, MD
Display date: 
Apr 19, 2018

When and why were the Beers criteria set in place? Learn more in this quiz.

©Michael Taylor/Shutterstock.com

6 New Drugs for Neurologists

  • Susan Kweskin
Apr 18, 2018

Newly approved medications for various types of pain, generalized myasthenia gravis, and Parkinson disease will be fodder for discussion at AAN 2018. Here’s a brief overview of the therapies the FDA has approved within the past 6 months.

©Nerthuz/Shutterstock

Ondine's Curse: Causes, Symptoms, and Treatment

  • Heidi Moawad, MD
Apr 17, 2018

Ondine’s curse has long been recognized as a congenital disorder and can also develop later in life as a result of damage to the lower lateral medulla. There are only a few cases—about 200 to 500 worldwide—each year.

Browse more articles

Resource Topics rightRail

  • Resource Topics
  • Partner Content
Headache and Migraine
There is currently no available content. Please check back soon.
Connect with Us
  • Twitter
  • Facebook
  • Google+
  • LinkedIn
  • RSS
Modern Medicine Network
  • Home
  • About Us
  • Advertise
  • Advertiser Terms
  • Privacy statement
  • Terms & Conditions
  • Editorial & Advertising Policy
  • Editorial Board
  • Contact Us
Modern Medicine Network
© UBM 2018, All rights reserved.
Reproduction in whole or in part is prohibited.